Comments to FDA: Remote Regulatory Assessments Draft Guidance Share page: Docket Number: FDA-2022-D-0810 CHPA appreciates the opportunity to provide comments on FDA Remote Regulatory Assessments Draft Guidance. Download Document Issues: OTC Medicines Dietary Supplements OTC Medical Devices Related Posts Letter Letter Regarding Office of Management & Budget Request for Information: Deregulation May 12, 2025 Press Releases and Statements Veteran Scientist & Regulator Joins CHPA’s Senior Management Team May 12, 2025 Press Releases and Statements CHPA Submits Official Comments on Section 232 National Security Investigation of Pharmaceuticals May 8, 2025